Chemistry:Relmapirazin

From HandWiki
Revision as of 19:20, 5 February 2024 by Wikisleeper (talk | contribs) (url)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Relmapirazin
Relmapirazin.svg
Clinical data
Trade namesLumitrace
Other namesMB-120
Legal status
Legal status
  • Investigational
Identifiers
CAS Number
PubChem CID
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC12H16N6O8
Molar mass372.294 g·mol−1
3D model (JSmol)

Relmapirazin (MB-120) is an investigational fluorescent tracer that is exclusively excreted renally and is used to measure glomerular filtration rate of the kidneys.[1][2][3][4][5][6][7]

References

  1. Dorshow, Richard B.; Shieh, Jeng-Jong; Debreczeny, Martin P. (17 March 2023). "Clinical results from a pilot multi-center study using a novel fluorescent tracer agent for renal function measurement". Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications XIV. pp. 19. doi:10.1117/12.2648541. ISBN 9781510659018. 
  2. Orieux, Arthur; Samson, Chloé; Pieroni, Laurence; Drouin, Sarah; Dang Van, Simon; Migeon, Tiffany; Frere, Perrine; Brunet, Dorothée et al. (5 June 2023). "Pulmonary hypertension without heart failure causes cardiorenal syndrome in a porcine model" (in en). Scientific Reports 13 (1): 9130. doi:10.1038/s41598-023-36124-1. ISSN 2045-2322. PMID 37277538. Bibcode2023NatSR..13.9130O. 
  3. Jang, Soo M.; Shieh, Jeng-Jong; Riley, Ivan R.; Dorshow, Richard B.; Mueller, Bruce A. (July 2023). "Adsorption and Clearance of the Novel Fluorescent Tracer Agent MB-102 During Continuous Renal Replacement Therapy: In Vitro Results". ASAIO Journal 69 (7): 702–707. doi:10.1097/MAT.0000000000001943. ISSN 1058-2916. PMID 37071749. PMC 10298171. https://journals.lww.com/asaiojournal/fulltext/2023/07000/adsorption_and_clearance_of_the_novel_fluorescent.19.aspx. 
  4. Rosner, Mitchell H.; Sprangers, Ben; Sandhu, Geeta; Malyszko, Jolanta (November 2022). "Glomerular Filtration Rate Measurement and Chemotherapy Dosing". Seminars in Nephrology 42 (6): 151340. doi:10.1016/j.semnephrol.2023.151340. PMID 37086497. 
  5. McMahon, Blaithin A.; Rosner, Mitchell H. (February 2020). "GFR Measurement and Chemotherapy Dosing in Patients with Kidney Disease and Cancer". Kidney360 1 (2): 141–150. doi:10.34067/KID.0000952019. PMID 35372903. 
  6. Schneider, Antoine G.; Molitoris, Bruce A. (December 2020). "Real-time glomerular filtration rate: improving sensitivity, accuracy and prognostic value in acute kidney injury". Current Opinion in Critical Care 26 (6): 549–555. doi:10.1097/MCC.0000000000000770. PMID 33002974. 
  7. Dorshow, Richard B.; Johnson, James R.; Shieh, Jeng-Jong; Riley, I. Rochelle; Rogers, Thomas E.; Pino, Christopher J.; Johnston, Kimberly A.; Tang, Peter et al. (July 2023). "Transdermal Detection of MB-102 and Correlation to Meropenem Pharmacokinetics During Continuous Renal Replacement Therapy: In Vivo Results". ASAIO Journal 69 (7): 708–715. doi:10.1097/MAT.0000000000001945. PMID 37097973.